Internal Medicine Residency, National University Health System, Singapore.
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Neurology, Department of Medicine, National University Health System, Singapore.
J Am Soc Echocardiogr. 2021 Oct;34(10):1056-1066. doi: 10.1016/j.echo.2021.04.008. Epub 2021 Apr 16.
Calcium deposits in the heart have been associated with cardiovascular events, mortality, stroke, and atrial fibrillation (AF). However, there is no accepted standard method for scoring cardiac calcifications. Existing methods have also not been validated for the assessment of patients with embolic stroke of undetermined source (ESUS). The aim of this study was to evaluate the association of various cardiac calcification scores with new-onset AF and stroke recurrence in a cohort of patients with ESUS.
In this study, 181 consecutive patients with stroke diagnosed with ESUS were identified and evaluated. They were followed for new-onset AF and ischemic stroke recurrence for a median duration of 2.1 years. Various echocardiographic cardiac calcification scores were assessed on transthoracic echocardiography performed during the evaluation of ESUS and subsequently assessed for their relation to AF detection and recurrent stroke. The echocardiographic calcium scores assessed were the (1) global cardiac calcium score (GCCS), (2) echocardiographic calcium score (eCS), (3) echocardiographic calcification score, (4) echocardiographic composite cardiac calcium score, and (5) total heart calcification score. Only two of these scoring schemes, GCCS and eCS, quantified the cardiac calcium burden.
Higher calcium scores as measured by GCCS and eCS were found to be significantly associated with subsequent AF detection as well as recurrent ischemic stroke in patients with ESUS. The association with recurrent stroke remained significant even after adjustment for comorbidities and AF.
Higher cardiac calcification measured using the GCCS and eCS is independently associated with AF detection and recurrent ischemic stroke in patients with ESUS, and these scores can be useful markers for further risk stratification in patients with ESUS.
心脏中的钙沉积与心血管事件、死亡率、中风和心房颤动(AF)有关。然而,目前还没有被广泛接受的心脏钙化评分标准方法。现有的方法也没有经过评估栓塞性卒中来源不明(ESUS)患者的验证。本研究的目的是评估各种心脏钙化评分与 ESUS 患者新发 AF 和中风复发的相关性。
本研究纳入了 181 例经 ESUS 诊断为中风的连续患者,并对其进行了评估。中位随访时间为 2.1 年,随访新发 AF 和缺血性中风复发。在评估 ESUS 期间进行的经胸超声心动图检查中评估了各种超声心动图心脏钙化评分,并随后评估了它们与 AF 检出和复发性中风的关系。评估的超声心动图钙评分包括:(1)整体心脏钙评分(GCCS);(2)超声心动图钙评分(eCS);(3)超声心动图钙化评分;(4)超声心动图复合心脏钙评分;(5)总心脏钙化评分。只有这两种评分方案(GCCS 和 eCS)量化了心脏钙负担。
发现 GCCS 和 eCS 测量的钙评分越高,与 ESUS 患者随后的 AF 检出以及复发性缺血性中风显著相关。即使在调整了合并症和 AF 后,与复发性中风的关联仍然显著。
使用 GCCS 和 eCS 测量的更高心脏钙化与 ESUS 患者的 AF 检出和复发性缺血性中风独立相关,这些评分可作为 ESUS 患者进一步风险分层的有用标志物。